• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: UNITED THERAPEUTICS CORPORATION TD300 TYVASO INHALATION SYSTEM; NEBULIZER (DIRECT PATIENT INTERFACE)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

UNITED THERAPEUTICS CORPORATION TD300 TYVASO INHALATION SYSTEM; NEBULIZER (DIRECT PATIENT INTERFACE) Back to Search Results
Device Problems Break (1069); Output Problem (3005)
Patient Problems Headache (1880); Low Blood Pressure/ Hypotension (1914); Sore Throat (2396); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Type  Injury  
Event Description
Patient reported that she has been hospitalized as of (b)(6) 2023 for complications related to her pulmonary arterial hypertension.Patient was in the intensive care unit (for about 2 weeks) when one of her nebulizers stopped working.A pharmacist advised her to use her backup and call cvs when she was feeling better to report the malfunction.Patient reported that she is on the pulmonary transplant unit and the nurses there were assisting her with the tyvaso nebulizer.One of the nurses reported to the patient that the nebulizer stopped working and that they were unable to charge it because the part on the device for charging had broken off.Patient does not have the malfunctioned device and does not know where it is since she was recently moved from the intensive care unit to another floor.Unk if it's user error.Pt has been experiencing headaches, sore throat, fluid overload, and hypotension, unk if doctor (b)(6) is aware but there is a team managing her therapy while in pt.Length of hospitalization is ongoing.Anticipated discharge date not specified; tyvaso nebulizer pt.The suspect device serial number was not provided by the pt.Per the pharmacy dispensing system, the following device serial numbers are currently checked out by the pt; for use: (b)(6) no due dates available.Pt is actively taking tyvaso and adcirca.Reported to cvs/caremark by pt/caregiver.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TD300 TYVASO INHALATION SYSTEM
Type of Device
NEBULIZER (DIRECT PATIENT INTERFACE)
Manufacturer (Section D)
UNITED THERAPEUTICS CORPORATION
MDR Report Key17217888
MDR Text Key318138240
Report NumberMW5118874
Device Sequence Number1
Product Code CAF
Combination Product (y/n)Y
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 06/22/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/27/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Is the Reporter a Health Professional? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient SexFemale
-
-